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Abstract
Common infectious agents, such as Toxoplasma gondii (T. gondii) and several human herpes viruses, have been linked to 
increased risk of self-harm. The aim of this study was to investigate the associations between self-harm and seropositivity 
to T. gondii, Epstein-Barr virus (EBV), Herpes Simplex virus Type 1 (HSV-1), and Cytomegalovirus (CMV). IgM and IgG 
antibodies to these infections were measured in the Health 2000 project nationally representative of the whole Finnish adult 
population, and 6250 participants, age 30 and over, were followed for 15 years via registers. In addition, lifetime suicidal 
ideation and suicide attempts based on medical records and interview were assessed within a subsample of 694 participants 
screened to a substudy for possible psychotic symptoms or as controls. Among the 6250 participants, 14 individuals died of 
suicide and an additional 4 individuals had a diagnosis of intentional self-harm during follow-up. Serological evidence of 
lifetime or acute infections was not found to be associated with these suicidal outcomes. However, in the subsample, those 
seropositive for CMV had fewer suicide attempts compared to those seronegative, adjusting for gender, age, educational 
level, childhood family size, regional residence, CRP, and screen status (OR for multiple attempts = 0.40, 95% confidence 
interval 0.20‒0.83, p = 0.014). To conclude, common infections were not associated with risk of death by suicide or with 
self-harm diagnoses at a 15-year follow-up in the general population sample. Our finding of an increased number of suicide 
attempts among persons seronegative for CMV calls for further research.
Keywords Toxoplasma gondii · Herpes · Cytomegalovirus (CMV) · Epstein–Barr virus (EBV) · Herpes simplex virus 1 
(HSV-1) · Suicide attempt
Introduction
The association between mental health and common infec-
tion agents has been an increasing area of investigation. 
The specific infections of interest particularly include 
Toxoplasma gondii (T. gondii) and several infections of 
the herpesvirus family, such as Cytomegalovirus (CMV), 
Epstein–Barr virus (EBV), and Herpes Simplex virus Type 
1 (HSV-1), all infections that primarily often are asymp-
tomatic or cause only mild symptoms, but form a lifelong 
latent infection and can later reactivate. Immunoglobulin G 
(IgG) antibodies to these infections indicate lifetime infec-
tion, whereas immunoglobulin M (IgM) antibodies may 
arise during primary infections or reactivation of infection.
Toxoplasma gondii is an intracellular parasite, most com-
monly spread by food or water that is contaminated with 
oocysts shed by cats, or by eating meat-containing tissue 
cysts, whereas the herpes viruses spread mostly through 
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bodily fluids, and are among the most common viruses in 
humans. In recent studies of the general population in Fin-
land, the seropositivity prevalence in adults was 20% for T. 
gondii [1], 72% for HSV-1 [2], 84% for CMV, and 98% for 
EBV [3]. Associations between these infections and men-
tal health have been repeatedly found. Toxoplasma may be 
associated with several mental disorders [4–7]. We have 
previously published cross-sectional results on the associa-
tion between IgG antibodies against T. gondii and anxiety 
disorders and depressive and psychotic-like symptoms [1, 
8]. Furthermore, CMV has been linked to psychiatric disor-
ders [9–12]. Interestingly, in one study, CMV seropositivity 
influenced mood disorders differentially among males and 
females, associating with carrying a lower risk of mood dis-
orders in males [13]. Also, the association between mental 
health and HSV-1 and EBV [10, 11, 13–21] has been stud-
ied, with somewhat conflicting results.
In addition to mood and emotions, inflammation and 
infections can also affect behavior [22, 23]. The association 
between exposure to infectious agents and suicidal behavior 
has recently raised interest, both in population and clinical 
studies. Comparing 20 European nations, the prevalence 
of T. gondii was positively correlated with national suicide 
rates [24], especially in women of postmenopausal age [25]. 
In a birth-cohort, there was a trend between toxoplasma IgG 
antibodies and suicide attempts [26] and in a large popula-
tion cohort, toxoplasma infection was found to be associated 
with risk of self-directed violence in women [27]. Toxo-
plasma serointensity has also been associated with suicide 
attempts in psychiatric outpatients [28] and individuals with 
mood disorders [29]. However, conflicting results have also 
been published in schizophrenia patients [30, 31].
In individuals with serious mental illness, those having 
a lifetime suicide attempt had elevated levels of IgM class 
antibodies to both T. gondii and CMV, and also an associa-
tion between the levels of these antibodies and the number 
of suicide attempts was found, whereas IgG class or EBV 
antibodies were not associated with suicide attempts [32]. 
In participants with schizophrenia or mood disorders, CMV 
antibodies were associated with risk of suicide, while HSV-1 
and EBV antibodies were not [33]. In another study in the 
general population, HSV-1 infection was associated with 
suicidal behavior [34]. A few other studies have not found 
evidence of association between seropositivity for CMV or 
HSV-1 and nonfatal suicidal self-directed violence [35] or 
history of suicide attempt in schizophrenia [36].
One pathway by which infections may influence men-
tal health is inflammation occurring in the central nervous 
system. The relationship between the inflammatory marker 
C-reactive protein (CRP) and the studied infections is partly 
unknown. Higher CRP levels, measuring inflammation, have 
been reported to be associated with T. gondii seropositivity 
in our previous study [1] and other studies [37, 38] and the 
role of CRP has also been studied in the context of HSV-1, 
CMV, and EBV [34, 39, 40]. Inflammation may also trigger 
changes in affective and behavioral modulation, and inflam-
matory processes may have a role in suicidality [41].
Information on the possible association on common infec-
tions and suicidal outcomes may help prevent self-harm 
in the population, as the infections may be prevented and 
treated. In this study, we aimed to investigate whether toxo-
plasma and herpes infections have a role in the risk for death 
by suicide or intentional self-harm in the general population. 
For this purpose, the participants of the Health 2000 study, a 
large Finnish population survey, were followed-up longitu-
dinally in national health registers for 15 years. As depres-
sion is a major risk factor for suicidality [42], we investi-
gated whether being seropositive to the studied infectious 
agents at baseline was associated with a) baseline depressive 
symptoms, and b) death by suicide and self-harm during the 
follow-up.
In addition, we assessed suicidal ideation and suicide 
attempts retrospectively in a smaller subsample of par-
ticipants of the Health 2000 study, Psychoses in Finland, 
selected for possible psychotic symptoms or as controls, 
and who had been comprehensively assessed using medical 
records and interview data [43].
Methods
Study procedure and measuring of antibodies
Data from the Health 2000 (BRIF8901), a nationally repre-
sentative survey of the Finnish general population [44], were 
used. Altogether 8028 persons, aged 30 years and over, were 
sampled using stratified two-staged cluster sampling, with 
participants representing their age and gender group in the 
area where they lived. All participants gave written informed 
consent and the study was approved by the ethics commit-
tees of the Hospital District of Helsinki and Uusimaa and 
the Finnish Institute for Health and Welfare. The study was 
carried out in accordance with the Declaration of Helsinki.
The baseline study was conducted in 2000–2001. IgG 
antibodies to T. gondii, HSV-1, EBV, and CMV were meas-
ured at baseline from plasma samples of 6250 participants. 
CRP levels were analyzed from serum samples, taken at the 
same time as plasma samples. Beck Depressive Inventory 
(BDI, with 21 items) was completed at baseline by 5786 
(72%) of the participants, assessing current depressive 
symptoms [45]. IgM antibodies to T. gondii and CMV were 
measured from two subsamples, people who had partici-
pated in a substudy on psychotic disorders and symptoms 
(see “Psychoses in Finland substudy” section) and a matched 
case–control study of those who had attempted or committed 
suicide in the follow-up (see “15-year register follow-up” 
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section). By assessing both IgG and IgM markers, we hoped 
to differentiate recent infections from those that occurred 
years earlier.
The analyses were performed by solid-phase enzyme 
immunoassay as previously described [46]. The participants 
were rated seropositive for herpes viruses if their optimal 
density value was above or at the infection point in the sam-
ple distribution. 50 IU/ml was used as the cut-off for toxo-
plasma IgG seropositivity. The IgM values are expressed 
as a ratio of the raw value to a control run on each plate 
as well as plate adjusted to a mean = 2 and standard devia-
tion (SD) = 1, where a value of 3 or greater represented 1 
SD greater than the mean of the population and was used 
as the cutoff point for seropositivity. In addition, serointen-
sity, defined as the quantitative level of antibody in terms of 
standardized units, was used as a continuous variable.
15‑year register follow‑up
Two registers were used to gather follow-up data on the total 
participant group of 6250 persons. Data on suicide deaths 
was available until the end of the year 2015 from the Causes 
of Death statistics (Statistics Finland), yielding a register 
follow-up time of approximately 15 years. The register con-
tains information on date and cause of all deaths in Fin-
land. Second, data on intentional self-harm were acquired 
from the Finnish hospital discharge database, a part of the 
Care Registration for Health Care (HILMO) up to the end of 
2015, consisting of data from both inpatient and outpatient 
settings. The intentional self-harm outcome included ICD-
10 diagnoses X60–X84, Y87.0, Z72.8, and Z91.5.
Psychoses in Finland substudy
Between December 2001 and January 2005, a subsample 
of the Health 2000 survey participants took part in the Psy-
choses in Finland (PIF) substudy [47]. A total of 746 par-
ticipants were screened to this substudy based on suspected 
psychosis, either based on baseline general population study 
or national registers (Fig. 1). All participants gave written 
informed consent. People with hospital treatment or medica-
tion for psychosis were included in the PIF study, as were 
individuals on disability pension because of a severe mental 
disorder, which could be a depressive disorder. The PIF par-
ticipants also included 174 control subjects assessed for the 
lifetime occurrence of suicidal ideation and behavior. The 
interval from the time of the Health 2000 main study, includ-
ing blood samples, to the interview about suicide behavior 
was 1.0‒4.3 years (mean 2.2, SD 0.7 years). Additionally, 
medical records from lifetime mental health treatment con-
tacts were reviewed, including those of participants selected 
to the PIF study who had not been interviewed. A best esti-
mate for suicidal thoughts and acts was made by experienced 
psychiatrists based on all available systematically evaluated 
information, including self-reported information, medical 
records, and health care registers [43]. The participants in 
this group consisted of 831 individuals, of whom 54.5% 
were female.
Deceased before interview n=51
Suicidality assessed with interview and/or case records n=831
Plasma data available n=694
Health 2000 study, two-stage cluster sample n=8028
Non-parcipants n=558 
(Refused n=416, lived abroad n=32,
not reached n=110)
Parcipants n=7419
Plasma data available n=6250
Baseline, 
year 2000
PIF subsample
follow-up, 
year 2001-2005
Register
follow-up, 
December
2015
Selected to the PIF 
substudy n=746
Naonal hospital discharge register,
the Causes of Death stascs n=6250
PIF screen:
Naonal registers, 
interview screen, 
self-reported or
physician assessed 
psychosis 
Controls of the PIF study 
n=174
Fig. 1  The participants of the register follow-up and the PIF subsample
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Data analyses
Analyses of the total sample were conducted taking into 
account the two-stage cluster sampling design using the 
survey package [48] of R. In addition, post-stratification 
weights were used to adjust for the oversampling of indi-
viduals aged 80 years and over and non-response, the 
results thus representing the whole Finnish adult popu-
lation. As post hoc analyses, we ran the same analyses 
among those seropositive for each infection, using anti-
body levels to predict the depressive symptoms or sui-
cide/self-harm. The significant analyses were repeated 
in females and males separately because of the previous 
gender-specific results.
Depression and infections
Cross-sectional associations of baseline BDI scores and 
seropositivity/antibody levels were calculated with lin-
ear regression models adjusting for background variables 
associated with infection seropositivity: gender, age, 
educational level, region of residence, and self-reported 
number of siblings (as a proxy for childhood family size). 
All IgG analyses were also adjusted for the plate used in 
the assays to account for a platform effect in running the 
assays. Of the linear models, unstandardized Beta values 
are reported.
15‑year register follow‑up
In the 15-year register follow-up, IgG levels were avail-
able from the whole sample at baseline. For IgM levels, a 
case–control approach was used: for each case (individual 
who had either died by suicide or had a self-harm diagno-
sis during the follow-up), the goal was to find 5 controls of 
the same age (± 2 years), gender, and health center district. 
Altogether 73 eligible matched controls were chosen (1‒5 
per case, mean 4.1, median 5).
Cox regression analyses predicting suicide/self-harm 
were conducted, with seropositivity for the chosen infec-
tions as the main predictor, while again adjusting for 
the same background variables. Hazard ratios (HR) are 
reported for these models.
Psychoses in Finland substudy
The PIF subsample analyses were conducted using IBM 
SPSS Statistics for Windows, version 25. We used binary 
logistic regression to investigate whether the seropositiv-
ity/antibody levels were associated with suicidal thoughts, 
and multinomial logistic regression to investigate whether 
they were associated with single or multiple suicide 
attempts, the reference category being No suicide attempts. 
Odds ratios (OR) are reported of the logistic models.
We controlled for gender, age, educational level, region 
of residence, number of siblings, screen status, and, at the 
last phase, CRP (as a logarithmic transformation), as we 
wanted to investigate whether the possible associations were 
explained by low-grade infection.
Results
The characteristics of the sample and the prevalences of the 
antibodies in the analysis groups can be seen in Table 1. 
We have previously reported that CRP was associated with 
IgG antibodies for T. gondii [1]. Adjusted for age and sex, 
higher CRP levels were also associated with seropositiv-
ity for HSV-1 IgG antibodies (p < 0.001) but not with other 
antibodies. CRP and BDI scores were negatively associated 
(p < 0.001).
Cross‑sectional associations of baseline depression 
and herpes infections
We used linear regression models controlling for gender, 
age, educational level, region of residence, and number 
of siblings to predict BDI scores, measuring self-reported 
depressive symptoms. Besides the previously reported asso-
ciation with T. gondii [1], we found no significant associa-
tions with the herpes infections (Table 2).
Female gender, older age, and low educational level 
remained as significant correlates of depressive symptoms 
in the models. Both depressive symptoms and seropositiv-
ity/antibody levels to the infections increased with age, the 
association between depressive symptoms and age being rel-
atively linear. Using age as a quadratic term did not change 
the results. Given the non-normal distribution of the BDI 
score, we also tried ordinal regression and Tobit regression 
models, with similar results.
The analyses were repeated using serointensity among 
those seropositive for each infection, and there were no sig-
nificant associations between serointensities and BDI score.
15‑year register follow‑up
Of the participants, 1629 of the original 8028 (20.3%) had 
died during the follow-up period; 15 (0.2%) of the deaths 
were recorded as suicides, and 14 of these individuals had 
given plasma samples at baseline in 2000. Two of the sui-
cide deaths were females and the other 12 were males. In 
addition, four individuals (two males and two females) had 
a treatment episode recorded with a diagnosis of inten-
tional self-harm (Z91.5, history of self-harm or Z72.8, 
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self-damaging behavior), after year 2000. Altogether 18 
individuals who had either died by suicide or had a self-
harm diagnosis during the follow-up and who had given a 
blood sample where thus defined as cases. In Cox regression 
models, male gender and Western and Northern regions of 
residence in Finland were associated with the case status, 
while none of the IgG or IgM seropositivity/antibody levels 
of any of the infections or CRP were significant predictors 
(Table 1).
We next ran the same Cox analyses using serointen-
sity among those seropositive for each infection. Among 
those seropositive for CMV, higher CMV IgG serointen-
sity predicted lower risk of self-harm (HR = 0.62, 95% CI 
0.43‒0.91, p = 0.014), when adjusting for gender, age, num-
ber of siblings, region of residence, and education. Other 
serointensity variables were not predictive of self-harm 
among those seropositive for that infection.
Psychoses in Finland subsample
Of the PIF participants, 694 of 831 had given plasma data 
at baseline, of whom 129 (18.6%) were included as con-
trol subjects (screen-negatives) and the rest were screened 
to the substudy based on self-reported or register-based 
suspicion of psychosis (screen-positives). According to 
the Structured Clinical Interview for DSM-IV (SCID-I) 
[49] and information from all medical records from life-
time mental health treatment contacts, 167 (24.1%) of the 
694 participants in the subsample were diagnosed with 
any lifetime DSM-IV psychotic disorder and 191 (27.5%) 
Table 1  Baseline characteristics and prevalences of the antibodies in the analysis groups
HR Hazard Ratio (95% CI, confidence interval), p value for the infection variable
a Calculated with weights to adjust for the oversampling of individuals aged ≥ 80 years and non-response. Prevalences (95% CI), or mean (95% 
CI). Only IgG levels available from the total sample
b N (%), or mean (SD), range
c Suicide or self-harm diagnosis during the 15-year register follow-up (cases), and the control subjects for them, matched for age, gender, and 
health center district
d Cox regression model predicting case status; adjusting for gender, age, educational level, region of residence, and number of siblings
Total sample, 
n = 6250a
PIF subsample 
n = 694b
Cases, n = 18b,c Matched controls, 
n = 73b,c
Cox model, HR (95% 
CI), p  valued
Females 52.2 (50.9‒54.0) % 370 (53.3%) 4 (22.2%) 20 (27.4%) –
Age 52.1 (51.7‒52.5) 52.7 (14.1), 30‒90 48.1 (12.2), 30‒71 49.1 (10.9), 30‒73 –
Basic education only 40.8 (39.4‒42.0) % 291 (41.9%) 3 (16.7%) 23 (31.5%) –
Number of siblings 3.8 (3.7‒3.8) 3.9 (2.9), 0‒18 3.7 (3.1), 0‒10 3.5 (2.8), 0‒14 –
Toxo IgG seroposi-
tivity
19.7 (18.3‒21.0) % 172 (24.8%) 4 (22.2%) 15 (20.5%) 1.91 (0.63, 5.76), 0.250
Toxo IgG antibody 
level
27.3 (26.1‒28.5) 31.0 (31.3), 
3.4‒179.4
29.2 (30.6), 8.1‒88.4 23.6 (25.4), 4.4‒120.7 1.01 (1.00, 1.02), 0.128
Toxo IgM seroposi-
tivity
N/A 119 (17.1%) 4 (25.0%) 13 (18.3%) 1.38 (0.37, 5.10), 0.634
Toxo IgM antibody 
level
N/A 2.0 (1.0), − 0.1 to 5.0 2.1 (1.0), 0.8‒4.0 1.9 (1.0), 0.4‒4.4 1.14 (0.66, 1.99), 0.643
CMV IgG seroposi-
tivity
83.5 (82.5‒84.0) % 583 (84.0%) 15 (83.3%) 59 (80.8%) 1.03 (0.30, 3.57), 0.957
CMV IgG antibody 
level
4.2 (4.1‒4.3) 4.2 (2.2), 0.1‒9.9 3.4 (1.7), 0.4‒5.7 3.6 (2.0), 0.3‒7.6 0.89 (0.74, 1.07), 0.238
CMV IgM seroposi-
tivity
N/A 114 (16.4%) 2 (12.5%) 6 (8.5%) 1.24 (0.18, 8.79), 0.828
CMV IgM antibody 
level
N/A 2.0 (1.0), 0.7‒6.1 1.8 (0.7), 0.8‒3.2 1.8 (0.8), 0.8‒4.2 0.88 (0.41, 1.89), 0.750
EBV IgG seroposi-
tivity
97.9 (97.5‒98.0) % 678 (97.7%) 18 (100%) 73 (100%) N/A
EBV IgG antibody 
level
1.5 (1.4‒1.5) 1.4 (0.7), 0.1‒4.5 1.5 (0.9), 0.4‒3.6 1.5 (0.7), 0.4‒3.7 0.98 (0.49, 1.96), 0.964
HSV-1 IgG seroposi-
tivity
71.2 (70.0‒72.0) % 496 (71.5%) 14 (77.8%) 47 (64.4%) 1.69 (0.55, 5.22), 0.360
HSV-1 IgG antibody 
level
3.7 (3.7‒3.8) 3.8 (2.8), 0.1‒16.9 3.8 (2.5), 0.2‒8.5 3.7 (3.3), 0.2‒12.7 1.01 (0.88, 1.15), 0.942
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had a mood disorder without a psychotic disorder. Of the 
rest, 120 (17.3%) had some other lifetime psychiatric 
diagnosis and 206 (29.7%) had no psychiatric diagnosis.
Suicidal thoughts in the subsample
A total of 218 of 694 (31.4%) had ever had suicidal thoughts 
based on interview and medical records. Suicidal thoughts 
were as common in males as in females and were signifi-
cantly associated with psychotic (p < 0.001) and mood dis-
order (p < 0.001) diagnoses and with entering the study as 
screen-positive (p < 0.001) but not with CRP (p = 0.525). 
There were no significant associations between suicidal 
thoughts and infection seropositivity/antibody levels 
(Table 3).
Suicide attempts in the subsample
A total of 90 of 694 (13.0%) of the subsample had a history 
of a suicide attempt, 42 (6.1%) once and 48 (6.9%) multiple 
times, with no significant gender differences. Of those with 
a history of a suicide attempt, 54 (60.0%) had a psychosis 
diagnosis and 29 (32.2%) had a mood disorder without a 
psychotic disorder. Suicide attempts were associated with 
psychotic (p < 0.001) and mood disorder (p < 0.001) diagno-
ses, with entering the study as screen-positive (p = 0.007), 
and with higher CRP (p = 0.004).
In multinomial logistic regression models adjusting for 
gender, age, education, number of siblings, region of resi-
dence, and screen status (Table 3), CMV IgG seropositivity 
was associated with fewer suicide attempts (OR for multi-
ple attempts = 0.45, 95% confidence interval (CI) 0.22‒0.91, 
p = 0.026). When CRP was also controlled for, CMV sero-
positivity remained a significant predictor (OR = 0.40, 95% 
Table 2  Linear regression models predicting baseline depressive 
symptoms (BDI score)
All models adjusting for gender, age, educational level, region of resi-
dence, number of siblings, and IgG analyses also for plate
Association with IgG levels, n = 5786, weighted to adjust for the 
oversampling of individuals aged ≥ 80 years and non-response. Asso-
ciation with IgM levels, n = 705
Significant values in bold
Beta value p value
Toxoplasma IgG seropositivity 0.51 0.035
Toxoplasma IgG antibody level 0.01 0.060
Toxoplasma IgM seropositivity 0.80 0.421
Toxoplasma IgM antibody level  − 0.23 0.546
CMV IgG seropositivity 0.12 0.631
CMV IgG antibody level 0.02 0.588
CMV IgM seropositivity 0.75 0.469
CMV IgM antibody level 0.17 0.669
EBV IgG seropositivity 0.39 0.479
EBV IgG antibody level  − 0.06 0.667
HSV-1 IgG seropositivity 0.11 0.600
HSV-1 IgG antibody level 0.016 0.631
Table 3  Logistic regression 
models predicting lifetime 
suicidal thoughts and attempts 
in the PIF subsample (n = 694)
All models adjusting for gender, age, educational level, region of residence, number of siblings, screen sta-
tus, and IgG analyses also for plate. Significant values in bold
CI confidence interval, OR odds ratio of the seropositivity or antibody level
a OR for suicidal thoughts, the reference category is No suicidal thoughts
b OR for multiple attempts, the reference category is No suicide attempts
Suicidal thoughts (no/yes) Suicide attempts (none/one/
multiple)
OR (95% CI)a p value OR (95% CI)b p value
Toxo IgG seropositivity 0.76 (0.50, 1.16) 0.196 0.98 (0.47, 2.08) 0.966
Toxo IgG antibody level 1.00 (0.99, 1.00) 0.125 1.00 (0.99, 1.01) 0.941
Toxo IgM seropositivity 1.06 (0.67, 1.67) 0.815 0.91 (0.38, 2.16) 0.828
Toxo IgM antibody level 1.08 (0.91, 1.29) 0.379 1.03 (0.74, 1.44) 0.846
CMV IgG seropositivity 0.85 (0.53, 1.37) 0.511 0.45 (0.22, 0.91) 0.026
CMV IgG antibody level 0.99 (0.91, 1.08) 0.796 0.92 (0.80, 1.07) 0.289
CMV IgM seropositivity 0.75 (0.46, 1.24) 0.261 0.61 (0.22, 1.68) 0.342
CMV IgM antibody level 0.97 (0.81, 1.16) 0.713 0.87 (0.62, 1.22) 0.413
EBV IgG seropositivity 0.60 (0.19, 1.83) 0.365 0.46 (0.92, 2.33) 0.350
EBV IgG antibody level 1.01 (0.76, 1.33) 0.958 1.18 (0.72, 1.92) 0.518
HSV-1 IgG seropositivity 1.15 (0.77, 1.73) 0.485 0.88 (0.44, 1.75) 0.716
HSV-1 IgG antibody level 1.00 (0.94, 1.07) 0.968 0.94 (0.83, 1.06) 0.331
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CI 0.20‒0.83, p = 0.014; Supplementary Table 4). Further 
post hoc analyses revealed that the association between 
CMV seropositivity and history of a suicide attempt was 
significant among the persons with a mood disorder (OR for 
multiple attempts = 0.17, 95% CI 0.05‒0.58, p = 0.005) but 
not among those with a psychotic disorder (p = 0.313) or the 
participants with neither diagnosis (p = N/A).
In post hoc analyses looking at males and females sepa-
rately, there were significant associations only in males: 
seropositivity for CMV was again associated with fewer 
suicide attempts (OR for multiple attempts = 0.26, 95% 
CI 0.10‒0.69, p = 0.006); controlling also for CRP did not 
change the result (OR = 0.26, 95% CI 0.10‒0.71, p = 0.008). 
Lower CMV IgG antibody levels were significantly associ-
ated with males’ multiple suicide attempts also using the 
intensity of antibodies (OR = 0.77, 95% CI 0.62‒0.96, 
p = 0.022), also when controlling for CRP (OR = 0.77, 
95% CI 0.61‒0.97, p = 0.027). In addition, in males, EBV 
serointensity was associated with suicide attempts (OR for 
one attempt versus no attempts = 2.12, 95% CI 1.12‒4.02, 
p = 0.022). EBV remained a significant predictor even 
when controlling for CRP (OR = 2.13, 95% CI 1.11‒4.09, 
p = 0.024; Supplementary Table 5).
Discussion
First, we found no significant cross-sectional associations 
between baseline depressive symptoms and antibody lev-
els to the herpes viruses EBV, CMV, or HSV-1 when con-
trolling for background variables associated with infection 
seropositivity. We have previously reported an association 
between T. gondii and depressive symptoms in this sample, 
even when adjusting for age, gender, region of residence, 
education, marital status, cat ownership, 12-month diagno-
ses, CRP, and antidepressant use [1]. Some previous studies 
have found CMV but not HSV-1 to be linked with depression 
[11, 14, 50], but the association between exposure to herpes 
infections and depressive symptoms has not been extensively 
studied.
Second, in a general population cohort of 6250 partici-
pants and 15-year follow-up using comprehensive register 
data and complete follow-up, seropositivity or antibody lev-
els of T. gondii or herpes viruses were not found to be asso-
ciated with suicides or diagnoses of intentional self-harm.
Third, we assessed suicidal ideation and suicide attempts 
in a subsample using information from medical records as 
well as data collected by questionnaire and interview. The 
participants of this subsample had either a severe psychiatric 
disorder or were controls; we controlled for this screen status 
in the regression models. A total of 31% of this subsample 
had had suicidal thoughts and 13% had attempted suicide 
during their lifetime. EBV antibody level was associated 
with a history of a suicide attempt in males, and none of 
the other infection variables added to the association with 
the suicide measures. However, those seropositive for IgG 
class antibodies for CMV, measuring latent infection, had 
fewer suicide attempts compared to those who were seron-
egative. This result was especially significant among male 
participants and also high CMV serointensity showed the 
same protective effect. The association was specific to CMV, 
as antibodies to the other studied herpes infections did not 
show the same relationship, and the association with EBV 
was in the opposite direction.
Converging evidence suggests that some common infec-
tious agents may predispose to mental disorders and disrupt 
affective and behavioral modulation [6, 12, 27, 51], hence 
also possibly elevating risk of self-harm. Only few prospec-
tive studies have been conducted [27, 33] and there are dif-
ferences between study design, seropositivity cut-offs used, 
populations studied, variables controlled for, and the time-
lines, which can all cause discrepancies between studies. 
Most of the previous studies have been conducted in clinical 
samples, only few studies concentrating on suicidality in the 
general population [26, 27]. Previous studies have reported 
self-harm to be associated with toxoplasma infection in the 
population especially in women [25, 27]. In psychiatric sam-
ples, antibodies for toxoplasma have been positively asso-
ciated with suicidality [28, 29, 32, 36, 52], however, not 
all studies have found such association [30, 31]. The differ-
ences between the current study and a similarly prospective 
study by Pedersen et al. [27] include their larger sample and 
a broader definition of the suicidal outcomes. The current 
study found no association between T. gondii antibodies and 
the suicidal outcomes of interest when controlling for the 
confounding variables, although T. gondii was associated 
with depressive symptoms [1].
The association between herpes viruses and suicidal-
ity has been studied scarcely [32–36] and mostly among 
psychiatric samples. In previous works, elevated CMV 
antibodies have been associated with suicide attempts or 
death by suicide in some psychiatric samples [32, 33] but 
not in all [36]. In a prospective study where elevated levels 
of CMV antibodies predicted suicide [33], the participants 
were mostly schizophrenia or bipolar disorder patients. In 
our study, we had the reverse result of lower CMV anti-
bodies associating with multiple suicide attempts, but the 
association was not significant among those with a psychotic 
disorder. In another previous work, IgG class antibodies 
against HSV-1 were associated with attempting or commit-
ting suicide in the general population [34]. A few previous 
studies have reported negative findings on the association 
between suicidality and EBV or HSV-1 [32, 33, 35, 36]; to 
our knowledge, our finding that higher EBV antibodies were 
associated with risk of a lifetime suicide attempt is new. 
In a previous longitudinal study, EBV antibody levels were 
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stable at the individual level but there was strong variation 
among individuals [53]. As overall EBV antibody level was 
measured here, the results could look different if we would 
measure specific EBV proteins, as was done by Dickerson 
and colleagues [20].
Although the prevalence of CMV in Finland has 
decreased significantly during recent decades [54], the rate 
was as high as 84% in the population at our baseline in year 
2000 [3]. The increased odds of multiple suicide attempts 
in persons belonging to the CMV seronegative minority is 
a new finding. In line with this was our post hoc result of 
higher CMV antibodies predicting lower risk of self-harm in 
the register follow-up among those seropositive for CMV. In 
the same sample as used in the current study, we have also 
found CMV to protect from new-onset generalized anxiety 
disorder, but not from new-onset depressive disorders or 
other anxiety disorders [55]. Low levels of CMV antibodies 
in affective disorders have also been found in other stud-
ies (Yolken et al., unpublished results). One previous study 
found that CMV seropositivity associated with higher risk 
of mood disorders in females, but—in line with our results—
with a lower risk in males [13]. The association between 
the immune system and mental health may be different in 
females and in males [13, 56, 57], although the reasons for 
this are still unclear, leading to a question whether gender 
differences may exist in the effect of infections on suicidal-
ity. As transmission of CMV requires intimate contact with 
other people, one could speculate whether persons seron-
egative for CMV have personality factors that predispose to 
suicidality as well, such as neuroticism [58] or social iso-
lation. However, HSV-1 and EBV have similar modes of 
person-to-person transmission as CMV, and our result was 
specific to CMV.
Attempting and dying by suicide may be associated 
with infections in different ways. Furthermore, we found 
that CMV seronegativity only added to the risk for several 
attempts but not to the risk for one attempt, when compared 
to no suicide attempts. Those attempting suicide once or 
several times can be clinically different populations, and the 
risk factors for single or repeated suicide attempts can be 
different [59].
Lower socioeconomic status is associated with seroposi-
tivity for CMV [60, 61]. In the general population, suicide 
risk is also associated with lower socioeconomic status [62, 
63]. Therefore, it seems surprising that antibodies for CMV 
were associated with lowered suicide risk. However, among 
patients treated for major depressive disorder, the associa-
tion between socioeconomic status and suicidality has been 
the opposite in Finland: higher educational level and family 
income predict suicide mortality [64]. In another Finnish 
study investigating people with depression-based disabil-
ity retirement, high socioeconomic position did not protect 
against unnatural and alcohol-related deaths, unlike in the 
general population [65]. Our result of the protective role of 
CMV was significant especially among those with mood 
disorders. It was not significant when only looking at those 
with psychotic disorder in the PIF subsample, and suicide 
attempts were not associated with educational level among 
those with a psychotic disorder in the PIF study [43]. In 
other words, the interplay among socioeconomic status, psy-
chiatric symptoms, and infections in regards to suicide risk 
seems to be complex.
Another factor to consider is general inflammation. 
Inflammatory processes may be linked to suicidality, and 
increased CRP levels are associated with mortality risk in 
people with mental disorders [66, 67]. The associations 
found in the PIF subsample remained when adjusting for 
CRP, so they were not explained by inflammation. Another 
reason why general activation of the immune system is not 
likely to explain our findings was that they were specific to 
certain infections.
Strengths and weaknesses
A number of limitations should be kept in mind when evalu-
ating the current results. Two samples were used in the study, 
both having their strengths and weaknesses. In the large 
general population of sample representative of the whole 
adult population in Finland, we were able to prospectively 
investigate the role of serological factors in suicide deaths 
and self-harm. Suicide deaths were reliably defined in the 
Causes of Death statistics, although the rareness of the out-
come severely limited the statistical power of the analyses. 
Power calculations show that with only 18 cases, to have a 
60% power, a HR as high as 3–4 would be needed. Only the 
most severe forms of intentional self-harm were captured in 
the health care register follow-up, and cases of self-harm not 
resulting in medical care or not diagnosed as self-harm were 
missed. Furthermore, IgM antibodies were only available 
for cases and matched controls and for the PIF subsample, 
while the whole sample could be used when investigating 
IgG levels. Furthermore, IgM levels informed whether the 
infection had occurred close to the baseline assessment, but 
we did not have information on IgM levels at the time of 
self-harm or suicide.
Using the smaller PIF subsample, we were able to assess 
suicidal ideation and suicide attempts more reliably, as con-
clusive, retrospective information from self-report, medi-
cal records, and health care registers was available. Persons 
with severe mental illness were enriched in this subsample, 
limiting the generalizability of these results to the general 
population, which is why we controlled for screen status and 
also looked at this subsample dividing it based on diagnosis 
group. The subsample was screened using multiple sources 
of information and included psychosis patients and individu-
als with any suspicion of psychotic illness as well as about 
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20% of matched healthy controls. One of the screens was 
disability pension based on a severe mental disorder (often 
depressive disorder) and suicidality was thus common in 
the subsample. In the subsample, lifetime suicidality was 
assessed, so the suicidal thoughts or acts may have happened 
before the blood sample was taken in year 2000. These kinds 
of differences in study design might explain some of the 
discrepancies noted among past studies. Genders were inves-
tigated separately in post hoc analyses but the small sample 
sizes limit the value of these findings, especially in females 
having small cell numbers in some analyses.
In analyzing the associations between infections and self-
harm, we adjusted for various background variables related 
to the measured infections, including demographic factors 
and inflammation. We did not assess for all the factors that 
could contribute to suicide such as trauma history, psychi-
atric symptoms, substance use, or personality factors [68]. 
Finally, multiple comparisons were not corrected for in this 
exploratory study. If the false discovery rate had been con-
trolled for using the Benjamini–Hochberg procedure [69], 
the associations would have not remained significant.
Conclusions
In a large sample representing the whole Finnish adult popu-
lation, antibodies to CMV, EBV, or HSV-1 were not associ-
ated with depressive symptoms. Antibodies to T. gondii or 
the herpes viruses were not associated with heightened risk 
for subsequent suicide deaths or diagnoses of intentional 
self-harm in a 15-year register follow-up. In a subsample 
consisting mostly of participants with severe mental disor-
ders, the infections were not associated with a heightened 
risk for suicidal thoughts or acts. However, the finding of 
heightened suicidality risk among persons not infected with 
CMV calls for further research.
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